PTGX | PROTAGONIST THERAPEUTICS INC

CUSIP: 74366E102

0 Funds Holding

0 Total Shares

$0 Total Value

$5.2B

Market Cap

124.9

P/E Ratio

52.6

Forward P/E

$0.66

EPS (TTM)

—

Dividend Yield

$576M

Cash

$11M

Total Debt

63M

Shares Out

$33.70

$96.54

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
No funds currently hold this stock.

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2025-Q3
Polen Capital Management	BUY	+27.0%	20.3K	$1M	$56.21
2025-Q2
Polen Capital Management	BUY	NEW	16.0K	$884265	$45.85

6 Months Insider Sentiment

100%

Buy $0 Sell $1.5M

0 Buys

4 Sells

-1.5M Net

10 Grants

Largest

$702K Waddill

$277K Waddill

$257K Waddill

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Jan 09, 2026	Harold E Selick	Director	EXERCISE	14.3K	$4.21	$60K
Jan 02, 2026	Arturo Molina MD	Chief Medical Officer	GRANT	25.6K	—	—
Jan 02, 2026	Asif Ali	Chief Financial Officer	GRANT	25.6K	—	—
Jan 02, 2026	Bryan Giraudo	Director	GRANT	2.7K	—	—
Jan 02, 2026	Harold E Selick	Director	GRANT	2.7K	—	—
Jan 02, 2026	Lewis T Williams	Director	GRANT	2.7K	—	—
Jan 02, 2026	William D. Waddill	Director	GRANT	2.7K	—	—
Jan 02, 2026	PATEL DINESH V PH D	President and CEO	GRANT	95.4K	—	—
Jan 02, 2026	Sarah A O'Dowd	Director	GRANT	2.7K	—	—
Nov 21, 2025	PATEL DINESH V PH D	President and CEO	GRANT	440	—	—
Nov 17, 2025	Arturo Molina MD	Chief Medical Officer	SELL	2.7K	$84.77	$230K
Oct 10, 2025	William D. Waddill	Director	EXERCISE	12.0K	$6.98	$84K
Oct 10, 2025	William D. Waddill	Director	SELL	4.0K	$69.25	$277K
Oct 10, 2025	William D. Waddill	Director	SELL	8.0K	$87.81	$702K
Sep 22, 2025	William D. Waddill	Director	SELL	4.0K	$64.25	$257K
Sep 16, 2025	PATEL DINESH V PH D	President and CEO	GRANT	620	—	—

Institutional Ownership of PROTAGONIST THERAPEUTICS INC